03:36 PM Abstract No. 320 Survival analysis of patients with hepatitis c and hepatocellular carcinoma receiving interventional oncology therapies and direct-acting antivirals with 12-week sustained viral response

To investigate the impact of direct-acting antivirals (DAA) and 12-week sustained viral response (SVR12) in patients with hepatocellular carcinoma (HCC) and hepatitis C (HCV) viral infections treated by interventional oncology (IO) therapies.

Source: Journal of Vascular and Interventional Radiology : JVIR - February 23, 2019 Category: Radiology Authors: W. Kamp, C. Sellers, S. Stein, J. Lim, H. Kim Tags: Scientific Session 33: IO IO, It ’s Off to Work We Go Source Type: research